1. Malek M, Nematbakhsh M. The preventive effects of diminazene aceturate in renal ischemia/reperfusion injury in male and female rats.
Adv Prev Med 2014:740647. 2014
2. Chang CH, Fan PC, Chang MY, et al. Acute kidney injury enhances outcome prediction ability of sequential organ failure assessment score in critically ill patients.
PLoS One 9:e109649.2014;
3. Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment.
J Renal Inj Prev 4:20–27. 2015;
4. Yap SC, Lee HT. Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence.
Anesthesiology 116:1139–1148. 2012;
5. Chertow GM, Lazarus JM, Paganini EP, Allgren RL, Lafayette RA, Sayegh MH. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group.
J Am Soc Nephrol 9:692–698. 1998;
6. Malek M, Hassanshahi J, Fartootzadeh R, Azizi F, Shahidani S. Nephrogenic acute respiratory distress syndrome: a narrative review on pathophysiology and treatment.
Chin J Traumatol 21:4–10. 2018;
7. Kelly KJ. Acute renal failure: much more than a kidney disease.
Semin Nephrol 26:105–113. 2006;
8. Doi K, Rabb H. Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets.
Kidney Int 89:555–564. 2016;
9. Vanholder R, Pletinck A, Schepers E, Glorieux G. Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update.
Toxins (Basel) 10:pii: E33. 2018
10. Hoke TS, Douglas IS, Klein CL, et al. Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury.
J Am Soc Nephrol 18:155–164. 2007;
11. Rabb H, Wang Z, Nemoto T, Hotchkiss J, Yokota N, Soleimani M. Acute renal failure leads to dysregulation of lung salt and water channels.
Kidney Int 63:600–606. 2003;
12. Karimi Z, Ketabchi F, Alebrahimdehkordi N, Fatemikia H, Owji SM, Moosavi SM. Renal ischemia/reperfusion against nephrectomy for induction of acute lung injury in rats.
Ren Fail 38:1503–1515. 2016;
13. Hassoun HT, Grigoryev DN, Lie ML, et al. Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy.
Am J Physiol Renal Physiol 293:F30–F40. 2007;
14. Chi OZ, Hunter C, Liu X, Tan T, Weiss HR. Effects of VEGF on the blood-brain barrier disruption caused by hyperosmolarity.
Pharmacology 82:187–192. 2008;
15. Sadik NA, Mohamed WA, Ahmed MI. The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis.
Mol Cell Biochem 359:73–81. 2012;
16. Burn DJ, Bates D. Neurology and the kidney.
J Neurol Neurosurg Psychiatry 65:810–821. 1998;
17. De Deyn PP, Saxena VK, Abts H, et al. Clinical and pathophysiological aspects of neurological complications in renal failure.
Acta Neurol Belg 92:191–206. 1992;
18. Chou AH, Lee CM, Chen CY, et al. Hippocampal transcriptional dysregulation after renal ischemia and reperfusion.
Brain Res 1582:197–210. 2014;
19. Fukunishi I, Kitaoka T, Shirai T, Kino K, Kanematsu E, Sato Y. Psychiatric disorders among patients undergoing hemodialysis therapy.
Nephron 91:344–347. 2002;
20. Liu M, Liang Y, Chigurupati S, et al. Acute kidney injury leads to inflammation and functional changes in the brain.
J Am Soc Nephrol 19:1360–1370. 2008;
21. Serlin Y, Shelef I, Knyazer B, Friedman A. Anatomy and physiology of the blood-brain barrier.
Semin Cell Dev Biol 38:2–6. 2015;
22. Ratliff BB, Rabadi MM, Vasko R, Yasuda K, Goligorsky MS. Messengers without borders: mediators of systemic inflammatory response in AKI.
J Am Soc Nephrol 24:529–536. 2013;
23. Patel JP, Frey BN. Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder?
Neural Plast 2015:708306. 2015
24. Fleegal-DeMotta MA, Doghu S, Banks WA. Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells.
J Cereb Blood Flow Metab 29:640–647. 2009;
25. Biancardi VC, Stern JE. Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension.
J Physiol 594:1591–1600. 2016;
26. Davis CJ, Kramár E, De A, et al. AT4 receptor activation increases intracellular calcium influx and induces a non-N-methyl-D-aspartate dependent form of long-term potentiation.
Neuroscience 137:1369–1379. 2006;
27. von Bohlen und Halbach O, Albrecht D. Mapping of angiotensin AT1 receptors in the rat limbic system.
Regul Pept 78:51–56. 1998;
28. AbdAlla S, Lother H, el Missiry A, et al. Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease.
J Biol Chem 284:6554–6565. 2009;
29. Labandeira-Garcia JL, Rodríguez-Perez AI, Garrido-Gil P, Rodriguez-Pallares J, Lanciego JL, Guerra MJ. Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration.
Front Aging Neurosci 9:129.2017;
30. Pan HL. Brain angiotensin II and synaptic transmission.
Neuroscientist 10:422–431. 2004;
31. Wei SG, Zhang ZH, Beltz TG, Yu Y, Johnson AK, Felder RB. Subfornical organ mediates sympathetic and hemodynamic responses to blood-borne proinflammatory cytokines.
Hypertension 62:118–125. 2013;
32. Konsman JP, Vigues S, Mackerlova L, Bristow A, Blomqvist A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli.
J Comp Neurol 472:113–129. 2004;
33. Jeong EG, Nam HS, Lee SM, An WS, Kim SE, Son YK. Role of B-type natriuretic peptide as a marker of mortality in acute kidney injury patients treated with continuous renal replacement therapy.
Ren Fail 35:1216–1222. 2013;
34. Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor.
Proc Natl Acad Sci U S A 100:1426–1431. 2003;
35. Costa MD, Bosc LV, Majowicz MP, Vidal NA, Balaszczuk AM, Arranz CT. Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats.
Hypertension 35:1119–1123. 2000;
36. Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances.
Pharmacol Rev 61:62–97. 2009;
37. Leaf DE, Waikar SS, Wolf M, Cremers S, Bhan I, Stern L. Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes.
Clin Endocrinol (Oxf) 79:491–498. 2013;
38. Haycock GB. Management of acute and chronic renal failure in the newborn.
Semin Neonatol 8:325–334. 2003;
39. Zhang M, Hsu R, Hsu CY, et al. FGF-23 and PTH levels in patients with acute kidney injury: a cross-sectional case series study.
Ann Intensive Care 1:21.2011;
40. Lourida I, Thompson-Coon J, Dickens CM, et al. Parathyroid hormone, cognitive function and dementia: a systematic review.
PLoS One 10:e0127574.2015;
41. Scaini G, Ferreira GK, Streck EL. Mechanisms underlying uremic encephalopathy.
Rev Bras Ter Intensiva 22:206–211. 2010;
42. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain.
Nat Rev Neurosci 9:46–56. 2008;
43. D’Mello C, Swain MG. Liver-brain inflammation axis.
Am J Physiol Gastrointest Liver Physiol 301:G749–G761. 2011;
44. Riazi K, Galic MA, Kentner AC, Reid AY, Sharkey KA, Pittman QJ. Microglia-dependent alteration of glutamatergic synaptic transmission and plasticity in the hippocampus during peripheral inflammation.
J Neurosci 35:4942–4952. 2015;
45. Hu H, Ho W, Mackie K, Pittman QJ, Sharkey KA. Brain CB
1 receptor expression following lipopolysaccharide-induced inflammation.
Neuroscience 227:211–222. 2012;
46. Watson CP, Pazarentzos E, Fidanboylu M, Padilla B, Brown R, Thomas SA. The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro.
Brain Res 1648:232–242. 2016;
47. Adachi N, Lei B, Deshpande G, et al. Uraemia suppresses central dopaminergic metabolism and impairs motor activity in rats.
Intensive Care Med 27:1655–1660. 2001;
48. Zhang N, Cheng GY, Liu XZ, Zhang FJ. Expression of Bcl-2 and NF-κB in brain tissue after acute renal ischemia-reperfusion in rats.
Asian Pac J Trop Med 7:386–389. 2014;
49. Karimi N, Haghani M, Noorafshan A, Moosavi SMS. Structural and functional disorders of hippocampus following ischemia/reperfusion in lower limbs and kidneys.
Neuroscience 358:238–248. 2017;
50. Tahamtan M, Moosavi SM, Sheibani V, Nayebpour M, Esmaeili-Mahani S, Shabani M. Erythropoietin attenuates motor impairments induced by bilateral renal ischemia/reperfusion in rats.
Fundam Clin Pharmacol 30:502–510. 2016;
51. Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA. Chronic kidney disease, creatinine and cognitive functioning.
Nephrol Dial Transplant 24:2446–2452. 2009;
52. Tsai HH, Yen RF, Lin CL, Kao CH. Increased risk of dementia in patients hospitalized with acute kidney injury: a nationwide population-based cohort study.
PLoS One 12:e0171671.2017;
53. Barzilay JI, Gao P, O’Donnell M. ONTARGET and TRANSCEND Investigators, et al. Albuminuria and decline in cognitive function: the ONTARGET/TRANSCEND studies.
Arch Intern Med 171:142–150. 2011;
54. Tahamtan M, Sheibani V, Shid Moosavi SM, et al. Pre-treatment with erythropoietin attenuates bilateral renal ischemia-induced cognitive impairments.
Iran J Pharm Res 17:601–612. 2018;
55. Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis.
J Am Soc Nephrol 24:353–363. 2013;